Table 5.
Effective assessment of INTP in trans breast endoscopic thyroidectomy.
| INTP group (n = 94) | Control group (n = 95) | p-Value | |
|---|---|---|---|
| EMG changes (%) | 1 (1.1%) | 8 (8.4%) | 0.018 |
| Hoarseness (%) | 1 (1.1%) | 4 (4.2%) | 0.178 |
| Postoperative PTH (pg/ml) | 38.7 ± 19.4 | 41.2 ± 16.2 | 0.329 |
| Postoperative calcium | 2.10 ± 0.10 | 2.13 ± 0.11 | 0.052 |
| Numbness in limbs (%) | 17 (18.1%) | 10 (10.5%) | 0.138 |
| Total number of CLN | 7.69 ± 5.71 | 7.35 ± 4.25 | 0.735 |
| Number of metastatic CLN | 0.83 ± 1.61 | 0.92 ± 1.52 | 0.706 |
| WBC (×109/L) | 8.7 ± 2.5 | 8.8 ± 2.5 | 0.741 |
| Postoperative CRP (mg/L) | 9.6 ± 6.7 | 8.7 ± 5.9 | 0.369 |
| Operative time (min) | 124.0 ± 50.2 | 120.7 ± 44.4 | 0.635 |
| Hospital stay (days) | 3.2 ± 1.1 | 3.4 ± 1.1 | 0.298 |
| Cosmetic satisfaction | 7.79 ± 0.77 | 7.69 ± 0.70 | 0.390 |
CLN, central lymph nodes; INTP, intraoperative neural tunnel protecting; EMG, electromyography; PTH, parathyroid hormone; WBC, white blood cell; CRP, C-reactive protein.